IDH1-MUTANT GLIOMA

Clinical trials for IDH1-MUTANT GLIOMA explained in plain language.

Never miss a new study

Get alerted when new IDH1-MUTANT GLIOMA trials appear

Sign up with your email to follow new studies for IDH1-MUTANT GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug combo tested for Hard-to-Treat brain tumors

Disease control Ongoing

This study is testing a new combination of two drugs, vorasidenib and temozolomide, for people with a specific genetic type of brain tumor called an IDH-mutant glioma. The first part of the study aims to find the safest and most effective dose. The second part will see how well t…

Matched conditions: IDH1-MUTANT GLIOMA

Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

IDH1-MUTANT GLIOMA

Get alerted when new IDH1-MUTANT GLIOMA trials appear

New drug combo tested for Hard-to-Treat brain tumors